Should women ever stop getting mammograms?

William Doss | | Radiology Business | Quality

Mammography screening is no stranger to controversy; it feels as if there's no end to the debates over the starting age and overall efficacy. However, there is no evidence that women should ever stop receiving them, according to Assistant Professor Ciny Lee, MD, of the University of San Francisco Department of Radiology.

Her study showed that as women aged, mammograms detected cancer at a higher rate with a decline in rates of recall. Utilizing data from the National Mammography Database, Lee and colleagues examined patient data from 2008 to 2014 using four performance metrics: cancer detection rate, recall rate and positive predictive value for biopsy recommendeded and for biopsy performed.

Follow the link below to watch an interview with Lee at RSNA 2016:

UCSF Study Finds No Evidence for Age-Based Mammography Cut-Off

William Doss

As a Senior Writer for TriMed Media Group, Will covers radiology practice improvement, policy, and finance. He lives in Chicago and holds a bachelor’s degree in Life Science Communication and Global Health from the University of Wisconsin-Madison. He previously worked as a media specialist for the UW School of Medicine and Public Health. Outside of work you might see him at one of the many live music venues in Chicago or walking his dog Holly around Lakeview.

Related Content

Patients frequently fail to obtain follow-up imaging. Could radiologist-referrer disagreements be to blame?
Hospitals pilot policies to test older radiologists’ mental and physical fitness
Does placing a patient’s photograph in the EHR influence radiologist behavior?
Most referrer requests for imaging are inadequate, new scoring system shows
Outsourced radiology reports less thorough than in-house ones, researchers claim
Effort to stop primary care providers from ordering low-value imaging hits brick wall

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
GE HealthCare moves PET/CT scanner production to United States

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.